Advancing Cancer Drug Development Using 2D and 3D Cell Panel Screens

GEN
America/Los_Angeles (PT) -7

Description

Leveraging screening of broad, diverse panels of cancer-relevant cell lines has historically yielded highly relevant data, which are used to identify mode-of-action, to expand disease or tissue efficacy, and to identify potential drug combinations. Results of such screens can drive the progression of novel oncology therapeutics from target validation through to the clinical phases of the discovery continuum. In this GEN webinar, we expand on how data generated from 2D cell panel single-agent and combination screens can complement data derived from a CRISPR knockout drug-gene interaction screen, leading to robust target identification and initial validation. The clinical-relevance of cell panel screens can be enhanced by integrating robust, high throughput methods for screening in three-dimensional models, including cell line-derived spheroids and patient-derived organoids. Finally, using selected case studies, we will highlight how 3D-specific phenotypic signatures align well with therapeutic target biology and the genetic background of the oncology model(s) being interrogated.

Advancing Cancer Drug Development Using 2D and 3D Cell Panel Screens

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Vicki Racicot

 

Link to the Event

Banner to the Event

Advancing Cancer Drug Development Using 2D and 3D Cell Panel Screens
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2021 "25 years inspiring technology"